Loading...
Chemical structure of Dapagliflozin

GC15530

Dapagliflozin

Also known as (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is a novel antidiabetic agent that is approved for the treatment of T2DM by based on its ability to inhibit SGLT2-mediated renal glucose reabsorption

ChemicalCAS461432-26-8MW408.87FormulaC21H25ClO6
CAS number
461432-26-8
Molecular weight
408.87
Formula
C21H25ClO6
Solubility
≥ 15·1mg/mL in DMSO, ≥ 116·6 mg/mL in EtOH
InChIKey
JVHXJTBJCFBINQ-ADAARDCZSA-N
Catalogue number
GC15530
Brand
GLPBIO
Computed properties PubChem CID 9887712 · XLogP 2.3 · TPSA 99.4 Ų · H-bond donors 4
XLogP
2.3
TPSA
99.4 Ų
H-bond donors
4
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
28

SMILES CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl

Computed descriptors from PubChem (CID 9887712), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.